The evolving therapeutic landscape of diabetic retinopathy

Shughoury, Aumer; Bhatwadekar, Ashay D.; Jusufbegovic, Denis; Hajrasouliha, Amir Reza; Ciulla, Thomas A.

doi:10.1080/14712598.2023.2247987

Cited by 4 publications

(1 citation statement)

References 187 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…VEGF signaling pathway inhibitors include monoclonal antibodies against VEGFA, vascular endothelial growth factor inhibitors (VEGF trap), monoclonal antibodies against VEGF receptors, and TKIs (Saif, 2013;Shughoury et al, 2023). TKIs are effective signaling cascade inhibitors that inhibit tumor blood vessel growth by inhibiting vascular endothelial growth factor receptor (VEGFR) (Vano et al, 2022).…”

Section: Relationship Between Vegf Signaling Pathway and Tki-induced ...mentioning

confidence: 99%

Microvascular rarefaction caused by the NOTCH signaling pathway is a key cause of TKI-apatinib-induced hypertension and cardiac damage

Wang,

Li,

et al. 2024

Front. Pharmacol.

View full text Add to dashboard Cite

With the advancement of tumour-targeted therapy technology, the survival of cancer patients has continued to increase, and cardiovascular events have gradually become an important cause of death in cancer patients. This phenomenon occurs due to adverse cardiovascular reactions caused by the cardiovascular toxicity of antitumour therapy. Moreover, the increase in the proportion of elderly patients with cancer and cardiovascular diseases is due to the extension of life expectancy. Hypertension is the most common cardiovascular side effect of small molecule tyrosine kinase inhibitors (TKIs). The increase in blood pressure induced by TKIs and subsequent cardiovascular complications and events affect the survival and quality of life of patients and partly offset the benefits of antitumour therapy. Many studies have confirmed that in the pathogenesis of hypertension, arterioles and capillary thinness are involved in its occurrence and development. Our previous findings showing that apatinib causes microcirculation rarefaction of the superior mesenteric artery and impaired microvascular growth may inspire new therapeutic strategies for treating hypertension. Thus, by restoring microvascular development and branching patterns, total peripheral resistance and blood pressure are reduced. Therefore, exploring the key molecular targets of TKIs that inhibit the expression of angiogenic factors and elucidating the specific molecular mechanism involved are key scientific avenues for effectively promoting endothelial cell angiogenesis and achieving accurate repair of microcirculation injury in hypertension patients.

show abstract

Section: Relationship Between Vegf Signaling Pathway and Tki-induced ...mentioning

confidence: 99%